Cellebrite DI Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 16, 2026, announcing a restructuring that reduced its global workforce by approximately 85 employees, or 7%.
Key Highlights
- Workforce reduction: Approximately 85 employees, representing 7% of the global workforce, were let go as part of a recently implemented restructuring.
- Restructuring charges: Cellebrite expects to incur charges of $2.5 million to $3.5 million, primarily related to one-time termination payments and related services.
- Completion timeline: The action is anticipated to be completed during the fourth quarter of 2026.
- Run-rate savings: The restructuring is expected to generate net annual run-rate savings of approximately $15 million to $17 million, with the vast majority anticipated to be realized in 2027.
- Reinvestment intent: According to the filing, Cellebrite expects to reinvest a portion of the anticipated savings in AI-native technologies and software development professionals.
- Guidance already updated: The filing states this action was already factored into the company's fiscal year 2026 guidance, which was updated on November 12.
Cellebrite Restructuring: Workforce, Charges, and Savings Details
Cellebrite DI Ltd. (NASDAQ:CLBT) disclosed in its Form 6-K, filed for the month of November 2026, that it recently implemented a restructuring affecting approximately 85 employees, equal to 7% of its global workforce. The company reported that it expects to incur restructuring charges in the range of $2.5 million to $3.5 million, with the filing specifying these costs are "primarily related to one-time termination payments and related services."
According to the filing, Cellebrite anticipates the action will be completed during the fourth quarter of 2026. The restructuring is projected to generate net annual run-rate savings of approximately $15 million to $17 million. The filing states that "the vast majority" of those savings will be realized in 2027. The company also disclosed its expectation to reinvest a portion of these savings in AI-native technologies and software development professionals, though no specific dollar amount for that reinvestment was provided in the filing.
The filing notes that this restructuring action was already factored into Cellebrite's fiscal year 2026 guidance, which the company updated on November 12. The 6-K was signed by David Barter, Chief Financial Officer. The filing contains forward-looking statements subject to the company's cautionary language, including risks related to macroeconomic conditions, competition, and execution of new offerings, among other factors described in the filing.
What Was Disclosed
Cellebrite DI Ltd. filed a Form 6-K disclosing a global workforce reduction of approximately 85 employees (7%), expected restructuring charges of $2.5 million to $3.5 million, and projected net annual run-rate savings of $15 million to $17 million, mostly anticipated in 2027.




Please wait processing your request...